Respirology Flashcards
(135 cards)
Diagnosis of ashtma on PFTs
PFTs showing obstructive lung disease =↓ FEV1/FVC <0.8
o Reversible (↑FEV1 improves >12% with b-agonists)
o Inducible with Methacoline: Done if FEV1/FVC is initially normal (FEV1 decreases 20% with methacholine)
It’s called reactive airway disease until recurrent presentations
Patient with daytime symtoms < 2 /wk, nocturnal symptoms < 2 / month, FEV1 > 80%. Asthma stage and tx?
Intermitent. Rescue SABA
Patient with daytime symtoms < 1 /day, nocturnal symptoms > 2 / month, FEV1 > 80%. Asthma stage and tx?
Mild persistent. Rescue SABA + low dose ICS*
- Could be replaced with Leukotriene Antagonist (e.g. Motelukast) or theophyline
Patient with daytime symtoms > 1 /day, nocturnal symptoms > 1 / week, FEV1 60-80%. Asthma stage and tx?
Moderate persistent. Rescue SABA + low dose ICS + LABA
ICS could be replaced with Leukotriene Antagonist (e.g. Motelukast)
Patient with daytime symtoms > 1 /day, nocturnal symptoms frequent, FEV1 < 60%. Asthma stage and tx?
Severe persistent. SABA + high dose ICS + LABA
ICS could be replaced with Leukotriene Antagonist (e.g. Motelukast)
Patient with severe persistent daytime and nocturnal symptoms. Asthma stage and tx?
Refractory. SABA + high dose ICS + LABA + PO steroids
But PO steroids should be avoided. Try anti IgE (omalizumab) if IgE related asthma.
ICS are interchangeable with…
LTA – Leukotrien receptor antagonis (e.g., montelukast)
Patient with asthma exacerbation + silent chest
Medical emergency that might need intubation
Rescue treatment for asthma exacerbation
racemic epinephrine, subcutaneous epinephrine, magnesium, nebulizer
Asthma exacerbation treatment
O2 for SATO2 > 92%
Short acting b-agonist: Neb/MDI (metered-dose inhaler)
Short acting anticholinergic: Neb/MDI
Steroids: methylprednisolone 125mg IV / prednisone 40-60 mg PO
Ambulatory tx after asthma exacerbation
B-agonist MDI + prednisone 1-2 mg/kg x 5 days
Types of emphysema
centriacinar (smokers) and panacinar (a1 antitrypsin deficiency)
Clinical characteristics of Emphysema:
- CO2 retention, no hypoxemia, ↑AP dyameter, prolong exhalation, dypnea, minimal cough
- Pink puffers
- Hypoxemia, pulmonary hypertension, CHF, edema, productive cough
- Blue bloaters
Dx?
Chronic Bronquitis
Tx COPD
- SABA (albuterol)
- SABA + long acting muscarinic antagonist – LAMA (tiotropium)
- SABA + LAMA + LABA (salmeterol)
- SABA + LAMA + LABA + ICS
- SABA + LAMA + LABA + ICS + Phosphodiesterase 4 inhibitors – PDE4-i (theophylline)
- SABA + LAMA + LABA + ICS + PDE4-i + steroids
Chronic treatment of COPD
- C: corticosteroids. ICS /Prednisone PO / methylprednisolone IV
- O: oxygen if SAT < 88% or PaO2 < 55. Goal, keep SAT 88-92%
- P: prevention. Influenza and Pneumococcal vaccines, and smoking cessation (first line)
- D: dilators: SABA, LABA, PO (e.g., PDE4-i, theophylin)
- E: experimental (surgery)
- R: rehab
Oxygen and prevention impruve survival
What prolongs survival in COPD?
Oxygen and smoke cessation
Anthonisen classification
COPD exacerbation:
* Wheezing/SOB
* Increased Sputum production
* Increased sputum purulence
I worse than III
Anthonisen I or II - - >AB
AB in COPD exacerbation
Amoxicillin-clavulanic acid (first line), doxycycline, azithromycin (do an ECG first to measure QT)
Bx modalities in lung cancer.
Large proximal lesions?
EBUS (Endobronchial ultrasound), e.g., Squamous cell carcinoma
Bx modalities in lung cancer.
Lesion in periphery?
CT-guided percutaneous Bx, e.g., Adenocarcinoma
Bx modalities in lung cancer.
In the lung
VATS (video-assisted thorascopic surgery)
Patient age > 55, quitted smoking <15 years ago, with spiculated nodule > 2 cm. Next step?
Resection of the lesion
Pleural effusion, thoracocentesis positive for malignancy. Stage of disease?
IV (metastasic)